Seeing Is Believing
Currently out of the existing stock ratings of Gregory Renza, 137 are a BUY (80.12%), 34 are a HOLD (19.88%).
Analyst Gregory Renza works at RBC with a stock forecast success ratio of 34.44% fulfilled within 121.29 days on average.
Gregory Renza’s has documented 336 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NRIX, Nurix Therapeutics at 11-Apr-2024.
Analyst best performing recommendations are on RXDX (PROMETHEUS BIOSCIENCES).
The best stock recommendation documented was for RXDX (PROMETHEUS BIOSCIENCES) at 12/7/2022. The price target of $111 was fulfilled within 1 day with a profit of $15.2 (15.87%) receiving and performance score of 158.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
37
$19.92 (116.63%)
42
3 days ago
25/34 (73.53%)
$20.29 (121.42%)
486
Buy
25
$7.92 (46.37%)
29
1 months 8 days ago
5/8 (62.5%)
$7.16 (40.13%)
26
Buy
30
$12.92 (75.64%)
40
1 months 20 days ago
16/19 (84.21%)
$10.44 (53.37%)
184
Buy
39
$21.92 (128.34%)
40
2 months 5 days ago
6/10 (60%)
$15.25 (64.21%)
94
Buy
33
$15.92 (93.21%)
33
2 months 5 days ago
8/19 (42.11%)
$9.25 (38.95%)
119
Which stock is Gregory Renza is most bullish on?
Which stock is Gregory Renza is most reserved on?
What Year was the first public recommendation made by Gregory Renza?